NEW YORK, NY - June 26, 2017 - InvestorsHub NewsWire
- Dewmar International BMC, Inc. (OTC
PINK: DEWM), a diversified brand management and
operating company that conducts business across variegated business
sectors, announced its Profit Reinvestment Program™ (PREP) which
was formed in 2015 to earmark up to $4,000,000 in retained earnings
towards a series of synergistic business opportunities with the
objective of creating diversified revenue streams for the
Company.
PREP™ Investments focused primarily on three sectors; these are:
(1) Healthcare Services/Technologies (2) Healthcare Real Estate and
(2) Entertainment/Media Investments.
The Company will announce investments in each sector over a
three-part series. This is Part 1 of that series and focuses on
investments made in Healthcare Services/Technologies.
1) Formation of Health & Wellness Research Consortium, LLC,
a wholly-owned subsidiary of Dewmar, whose objective is to develop,
implement and execute healthcare sales and marketing programs for
pharmacies, clinics and hospitals with the goal to help the client
improve patient care, broaden market presence, influence effective
prescribing behaviors and ultimately maximize their return on
assets.
2) Investment fund for the acquisition of Dimension Pharmacy, a
Texas retail specialty pharmacy.
3) Investment fund for the purchase of Medicine Shoppe, a
Louisiana traditional retail and specialty pharmacy combo.
4) Formation of Tri-Health Solutions, Inc., a wholly-owned
subsidiary of Dewmar, whose objective is to provide telemedicine
services to Mississippi, Louisiana and Texas based healthcare
systems.
5) Clinton Wellness Center, LLC investment
fund, a Mississippi urgent care clinic and telemedicine center.
6) First-round investor in CirrusMD, a leading national telemedicine and
acute care provider for large employers which recently announced
a $7 million Series A financing led by
Colorado Impact Fund, joined by Bootstrap Incubation, Three Leaf
Ventures, Rockies Venture Fund, Service Provider Capital, Sand Hill
Angels, and New York Angels.
"The accumulation of assets that would create revenue streams
for Dewmar, provide access to synergistic technologies, and/or
appreciate in value over time was the chief criteria I looked at
when considering investment opportunities," said Dr. Marco Moran, CEO & Founder of
Dewmar International. "As a licensed pharmacist with dual post
graduate degrees in Pharmaceutical Science and Business
Administration with a specialty in Healthcare, I am qualified and
comfortable assessing the long-term potential of investments in the
healthcare sector that can ultimately help Dewmar grow its
diversified revenue base," Dr. Moran continued. "It's rewarding to
know disciplined investors from Vestar Capital Partners and the
Colorado Impact Fund agree with my investment in CirrusMD in the
form of a follow-on $7 million Series A
financing in CirrusMD which makes investors in Dewmar a
big winner too!"
About Dewmar International BMC, Inc.
Dewmar International BMC, Inc. is a certified service-disabled
veteran owned business concern, new product development,
manufacturing and brand management company. Established in 2003,
Dewmar's primary business strategy has been in creating high profit
margins with functional foods and beverages, as well as introducing
new simple yet meaningful innovations to markets of great demand.
The Company's flagship product, Lean Slow Motion PotionTM, whose flavors
include Yella, Purp and Easta Pink, is rated as one of the top 3
national selling relaxation beverages in the U.S. market. The
company has offices in Clinton, MS; Houston, TX: Denver, CO and New
Orleans, LA.
Follow Dewmar on its official Facebook and Twitter sites where the CEO is inclined to
provide information, sometimes on a daily basis, about some of the
Company's current activities and key staff activities. Also,
subscribe to our Company Newsletter on the bottom right of
our homepage on our website to receive updates as well.
Click here for the Safe Harbor
Statement.